Fmr Llc - Net Worth and Insider Trading

Fmr Llc Net Worth

The estimated net worth of Fmr Llc is at least $305 Million dollars as of 2024-06-19. Fmr Llc is the See Remark 1 of Beam Therapeutics Inc and owns about 4,007,424 shares of Beam Therapeutics Inc (BEAM) stock worth over $93 Million. Fmr Llc is the Edward C. Johnson 3d of Xoom Corp and owns about 2,619,036 shares of Xoom Corp (XOOM) stock worth over $65 Million. Fmr Llc is also the Edward C. Johnson 3d of Exa Corp and owns about 2,105,640 shares of Exa Corp (EXA) stock worth over $51 Million. Besides these, Fmr Llc also holds Blueprint Medicines Corp (BPMC) , Insmed Inc (INSM) , Orchard Therapeutics PLC (ORTX) , Regenxbio Inc (RGNX) , Cogent Biosciences Inc (COGT) , Ironwood Pharmaceuticals Inc (IRWD) , Verve Therapeutics Inc (VERV) , Aclaris Therapeutics Inc (ACRS) , Precision BioSciences Inc (DTIL) , Coherus BioSciences Inc (CHRS) , Tetraphase Pharmaceuticals Inc (TTPH) , Proteostasis Therapeutics Inc (PTI) , ViewRay Inc (VRAYQ) . Details can be seen in Fmr Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Fmr Llc has not made any transactions after 2024-02-14 and currently still holds the listed stock(s).

Transaction Summary of Fmr Llc

To

Fmr Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Fmr Llc owns 35 companies in total, including Beam Therapeutics Inc (BEAM) , Orchard Therapeutics PLC (ORTX) , and Precision BioSciences Inc (DTIL) among others .

Click here to see the complete history of Fmr Llc’s form 4 insider trades.

Insider Ownership Summary of Fmr Llc

Ticker Comapny Transaction Date Type of Owner
BEAM Beam Therapeutics Inc 2024-02-14 10 percent owner & other: See Remark 1
ORTX Orchard Therapeutics PLC 2021-02-05 10 percent owner & other: See Remark 1
DTIL Precision BioSciences Inc 2019-04-01 10 percent owner & other: See Remark 1
LIMIT LIMIT 2018-08-08 10 percent owner & other: See Remark 1
LIMIT LIMIT 2018-04-18 10 percent owner & other: See Remark 1
LIMIT LIMIT 2017-12-07 10 percent owner & other: See Remark 1
LIMIT LIMIT 2018-04-03 10 percent owner & other: See Remark 1
LIMIT LIMIT 2018-01-24 10 percent owner & other: See Remark 1
LIMIT LIMIT 2017-11-07 other: See Remark 1
LIMIT LIMIT 2016-10-26 10 percent owner & other: See Remark 1
LIMIT LIMIT 2017-06-27 10 percent owner & other: See Remark 1
LIMIT LIMIT 2017-03-13 other: See Remark 1
LIMIT LIMIT 2016-09-30 other: See Remark 1
LIMIT LIMIT 2016-08-08 10 percent owner & other: See Remark 1
LIMIT LIMIT 2016-05-17 10 percent owner & other: See Remark 1
LIMIT LIMIT 2015-11-27 10 percent owner & other: See Remark 1
LIMIT LIMIT 2015-03-05 other: See Remark 1
LIMIT LIMIT 2014-01-30 10 percent owner & other: Edward C. Johnson 3d
LIMIT LIMIT 2014-06-30 10 percent owner & other: See Remark 1
LIMIT LIMIT 2014-05-27 other: Edward C. Johnson 3d
LIMIT LIMIT 2013-08-28 other: Edward C. Johnson 3d
LIMIT LIMIT 2013-07-22 10 percent owner & other: Edward C. Johnson 3d
LIMIT LIMIT 2013-03-28 10 percent owner & other: Edward C. Johnson 3d
LIMIT LIMIT 2016-02-10 10 percent owner & other: See Remark 1
LIMIT LIMIT 2021-05-25 10 percent owner & other: See Remark 1
LIMIT LIMIT 2021-07-22 10 percent owner & other: See Remark 1
LIMIT LIMIT 2021-09-24 10 percent owner & other: See Remark 1
LIMIT LIMIT 2021-07-29 10 percent owner & other: See Remark 1
LIMIT LIMIT 2021-10-21 10 percent owner & other: See Remark 1
LIMIT LIMIT 2022-07-12 10 percent owner & other: See Remark 1
LIMIT LIMIT 2022-10-19 10 percent owner & other: See Remark 1
LIMIT LIMIT 2023-02-02 10 percent owner & other: See Remark 1
LIMIT LIMIT 2016-02-10 10 percent owner & other: See Remark 1
LIMIT LIMIT 2023-07-20 10 percent owner & other: See Remark 1
LIMIT LIMIT 2023-09-14 10 percent owner & other: See Remark 1

Fmr Llc Latest Holdings Summary

Fmr Llc currently owns a total of 16 stocks. Among these stocks, Fmr Llc owns 4,007,424 shares of Beam Therapeutics Inc (BEAM) as of February 14, 2024, with a value of $93 Million and a weighting of 30.47%. Fmr Llc owns 2,619,036 shares of Xoom Corp (XOOM) as of August 28, 2013, with a value of $65 Million and a weighting of 21.41%. Fmr Llc also owns 2,105,640 shares of Exa Corp (EXA) as of July 3, 2012, with a value of $51 Million and a weighting of 16.75%. The other 13 stocks Blueprint Medicines Corp (BPMC) , Insmed Inc (INSM) , Orchard Therapeutics PLC (ORTX) , Regenxbio Inc (RGNX) , Cogent Biosciences Inc (COGT) , Ironwood Pharmaceuticals Inc (IRWD) , Verve Therapeutics Inc (VERV) , Aclaris Therapeutics Inc (ACRS) , Precision BioSciences Inc (DTIL) , Coherus BioSciences Inc (CHRS) , Tetraphase Pharmaceuticals Inc (TTPH) , Proteostasis Therapeutics Inc (PTI) , ViewRay Inc (VRAYQ) have a combined weighting of 31.38% among all his current holdings.

Latest Holdings of Fmr Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BEAM Beam Therapeutics Inc 2024-02-14 4,007,424 23.17 92,852,014
XOOM Xoom Corp 2013-08-28 2,619,036 24.91 65,240,187
EXA Exa Corp 2012-07-03 2,105,640 24.24 51,030,185
BPMC Blueprint Medicines Corp 2015-11-27 264,898 106.71 28,267,266
INSM Insmed Inc 2013-07-22 381,717 65.58 25,033,001
ORTX Orchard Therapeutics PLC 2021-02-05 1,019,908 16.70 17,032,464
RGNX Regenxbio Inc 2016-05-17 619,376 12.21 7,562,581
COGT Cogent Biosciences Inc 2018-04-03 603,148 8.50 5,126,758
IRWD Ironwood Pharmaceuticals Inc 2013-03-28 837,736 5.70 4,775,095
VERV Verve Therapeutics Inc 2022-07-12 570,729 5.10 2,910,718
ACRS Aclaris Therapeutics Inc 2016-10-26 2,571,354 1.13 2,905,630
DTIL Precision BioSciences Inc 2019-04-01 124,608 10.10 1,258,541
CHRS Coherus BioSciences Inc 2016-08-08 361,594 1.62 585,782
TTPH Tetraphase Pharmaceuticals Inc 2013-03-20 64,069 2.20 140,952
PTI Proteostasis Therapeutics Inc 2017-03-13 12,175 1.11 13,514
VRAYQ ViewRay Inc 2018-08-08 606,356 0.00 6

Holding Weightings of Fmr Llc


Fmr Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Fmr Llc has made a total of 4 transactions in Beam Therapeutics Inc (BEAM) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Beam Therapeutics Inc is the sale of 901,565 shares on February 14, 2024, which brought Fmr Llc around $28 Million.

According to the SEC Form 4 filings, Fmr Llc has made a total of 0 transactions in Xoom Corp (XOOM) over the past 5 years. The most-recent trade in Xoom Corp is the sale of 224 shares on August 28, 2013, which brought Fmr Llc around $6,241.

According to the SEC Form 4 filings, Fmr Llc has made a total of 0 transactions in Exa Corp (EXA) over the past 5 years. The most-recent trade in Exa Corp is the sale of 2,080,334 shares on July 3, 2012, which brought Fmr Llc around $19 Million.

More details on Fmr Llc's insider transactions can be found in the Insider Trading History of Fmr Llc table.

Insider Trading History of Fmr Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Fmr Llc Trading Performance

GuruFocus tracks the stock performance after each of Fmr Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fmr Llc is 40%. GuruFocus also compares Fmr Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fmr Llc within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Fmr Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Fmr Llc

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 29.04 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 27.48 LIMIT LIMIT LIMIT LIMIT LIMIT

Fmr Llc Ownership Network

Ownership Network List of Fmr Llc

No Data

Ownership Network Relation of Fmr Llc

Insider Network Chart

Fmr Llc Owned Company Details

What does Beam Therapeutics Inc do?

Who are the key executives at Beam Therapeutics Inc?

Fmr Llc is the 10 percent owner & other: See Remark 1 of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include Chief Medical Officer Amy Simon , President & CSO Giuseppe Ciaramella , and CFO Terry-ann Burrell .

Beam Therapeutics Inc (BEAM) Insider Trades Summary

Over the past 18 months, Fmr Llc made 1 insider transaction in Beam Therapeutics Inc (BEAM) with a net sale of 901,565. Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 114,771 shares made by Terry-ann Burrell , a net sale of 17,788 shares made by Christine Bellon , and a net sale of 43,625 shares made by Amy Simon .

In summary, during the past 3 months, insiders sold 115,170 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 115,170 shares. During the past 18 months, 1,332,241 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,332,241 shares.

Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Beam Therapeutics Inc Insider Transactions

No Available Data

Fmr Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Fmr Llc. You might contact Fmr Llc via mailing address: 245 Summer Street, Boston Ma 02210.

Discussions on Fmr Llc

No discussions yet.